BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 31398868)

  • 1. Comparison of Procalcitonin Assays on KRYPTOR and LIAISON
    Dipalo M; Gnocchi C; Avanzini P; Musa R; Di Pietro M; Aloe R
    Diagnostics (Basel); 2019 Aug; 9(3):. PubMed ID: 31398868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new sensitive automated assay for procalcitonin detection: LIAISON
    Fortunato A
    Pract Lab Med; 2016 Dec; 6():1-7. PubMed ID: 28856207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicenter comparison of automated procalcitonin immunoassays.
    Dipalo M; Guido L; Micca G; Pittalis S; Locatelli M; Motta A; Bianchi V; Callegari T; Aloe R; Da Rin G; Lippi G
    Pract Lab Med; 2015 Aug; 2():22-28. PubMed ID: 28932801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor.
    Ceriotti F; Marino I; Motta A; Carobene A
    Clin Chem Lab Med; 2017 Nov; 56(1):162-169. PubMed ID: 28809746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical evaluation of the novel Lumipulse G BRAHMS procalcitonin immunoassay.
    Ruzzenente O; Salvagno GL; Gelati M; Lippi G
    Pract Lab Med; 2016 Dec; 6():8-13. PubMed ID: 28856208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical evaluation of the novel VITROS BRAHMS procalcitonin immunoassay.
    Dupuy AM; Bargnoux AS; Montagnon V; Kuster N; Badiou S; Cristol JP
    Scand J Clin Lab Invest; 2020 Nov; 80(7):541-545. PubMed ID: 33124916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analytical Evaluation of the New Beckman Coulter Access Procalcitonin (PCT) Chemiluminescent Immunoassay.
    Lippi G; Salvagno GL; Gelati M; Pucci M; Demonte D; Faggian D; Plebani M
    Diagnostics (Basel); 2020 Feb; 10(3):. PubMed ID: 32111028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays.
    Lippi G; Salvagno GL; Gelati M; Pucci M; Lo Cascio C; Demonte D; Faggian D; Plebani M
    Clin Chem Lab Med; 2019 Dec; 58(1):77-84. PubMed ID: 31539351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a novel automated DiaSys procalcitonin immunoassay with four different BRAHMS-partnered immunoassays.
    Eidizadeh A; Wiederhold M; Schnelle M; Binder L
    Pract Lab Med; 2022 May; 30():e00274. PubMed ID: 35465623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical Evaluation of Point-of-Care Finecare™ Procalcitonin Rapid Quantitative Test in Sepsis Population as Compared with Elecsys
    Mazlan MZ; Wan Azman WN; Yaacob NM; Koon TS; Yahya NK
    Diagnostics (Basel); 2024 May; 14(11):. PubMed ID: 38893607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analytical evaluation of Lumipulse® BRAHMS PCT CLEIA assay and clinical performances in an unselected population as compared with central lab PCT assay.
    Dupuy AM; Né M; Bargnoux AS; Badiou S; Cristol JP
    Clin Biochem; 2017 Mar; 50(4-5):248-250. PubMed ID: 27838408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a fully automated procalcitonin chemiluminescence immunoassay.
    Hubl W; Krassler J; Zingler C; Pertschy A; Hentschel J; Gerhards-Reich C; Mack M; Demant T
    Clin Lab; 2003; 49(7-8):319-27. PubMed ID: 12908732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays.
    Wang D; Caddell B; Nolte FS; Babic N
    J Appl Lab Med; 2019 Jan; 3(4):580-586. PubMed ID: 31639727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of procalcitonin assay on the Abbott Architect i2000 SR® analyzer].
    El Mouatani A; Rotaru I; Beaudeux JL; Hennequin C
    Ann Biol Clin (Paris); 2018 Jun; 76(3):308-312. PubMed ID: 29622524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System.
    Steinbach G; Rau B; Debard AL; Javourez JF; Bienvenu J; Ponzio A; Bonfà A; Hubl W; Demant T; Külpmann WR; Buchholz J; Schumann G
    Clin Chem Lab Med; 2004 Apr; 42(4):440-9. PubMed ID: 15147156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of procalcitonin immunoassay concordance near clinical decision points.
    Chambliss AB; Hayden J; Colby JM
    Clin Chem Lab Med; 2019 Aug; 57(9):1414-1421. PubMed ID: 30763263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the New, Rapid, and Fully Automated Kryptor TSH receptor Antibodies Assay (B.R.A.H.M.S.) with the Radioimmunological Assay (B.R.A.H.M.S.).
    Chauvet J; Leven C; Thuillier P; Capaldo C; Moineau MP; Plée-Gautier E; Carré JL; Padelli M
    Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the novel ARCHITECT procalcitonin assay with established procalcitonin assay systems.
    Soh A; Binder L; Clough M; Hernandez MH; Lefèvre G; Mostert K; Nguyen TB; Otte KM; Portakal O; Sandri MS; Yen JL; Huang J; Beshiri A
    Pract Lab Med; 2018 Nov; 12():e00110. PubMed ID: 30519621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel chemiluminescence immunoassay for the detection of procalcitonin.
    Wang G; Wan Y; Lin G; Li Z; Dong Z; Liu T
    J Immunol Methods; 2020; 484-485():112829. PubMed ID: 32673618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Value of Procalcitonin in ANCA-Associated Vasculitis (AAV) to Differentiate Between Disease Activity, Infection and Drug Hypersensitivity.
    Herrmann K; Schinke S; Csernok E; Moosig F; Holle JU
    Open Rheumatol J; 2015; 9():71-6. PubMed ID: 26535070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.